Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 407 | 612 | 478 | 491 | 607 |
| Marketable Securities | 1,566 | 1,507 | 984 | 850 | 1,238 |
| Receivables | 2,586 | 2,925 | 2,851 | 2,914 | 3,108 |
| Inventories | 900 | 978 | 1,096 | 1,512 | 1,649 |
| TOTAL | $5,459 | $6,022 | $5,409 | $5,766 | $6,601 |
| Non-Current Assets | |||||
| PPE Net | 1,482 | 1,512 | 1,440 | 1,533 | 1,628 |
| Investments And Advances | 1,195 | 1,151 | 924 | 1,039 | 910 |
| Other Non-Current Assets | 51 | 56 | 25 | 31 | 36 |
| TOTAL | $2,728 | $2,718 | $2,389 | $2,603 | $2,574 |
| Total Assets | $8,187 | $8,740 | $7,798 | $8,369 | $9,175 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,531 | 1,964 | 1,315 | 1,448 | 1,876 |
| TOTAL | $1,563 | $2,004 | $1,335 | $1,503 | $1,985 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 36 | 40 | 14 | 18 | 22 |
| TOTAL | $66 | $71 | $40 | $45 | $63 |
| Total Liabilities | $1,630 | $2,075 | $1,375 | $1,547 | $2,047 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,447 | 1,447 | 1,447 | 1,447 | 1,426 |
| Common Shares | 10,930 | 10,930 | 10,930 | 10,930 | 10,780 |
| Retained earnings | 1,087 | 1,156 | 1,313 | 1,391 | 1,529 |
| Other shareholders' equity | -448 | -409 | -807 | -487 | -169 |
| TOTAL | $6,557 | $6,665 | $6,424 | $6,822 | $7,128 |
| Total Liabilities And Equity | $8,187 | $8,740 | $7,798 | $8,369 | $9,176 |